Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lupin Looks “Down Under” For Generic Growth As Deal Spree Continues

This article was originally published in The Pink Sheet Daily

Executive Summary

Indian firm buys stake in Australian generics, OTC firm Generic Health.

You may also be interested in...



World's Largest TB Drug Maker Lupin Acquires German Generic Company Hormosan To Extend Reach Into Europe

MUMBAI - Lupin, the world's largest manufacturer of anti-TB drugs, has acquired German generics firm Hormosan Pharma GmbH to establish a "bridgehead" and sharpen its focus in the European market

Lupin Says “Konnichi Wa” To Japanese Market With Majority Stake In Kyowa

Deal marks first major step for Indian pharma into Japan.

Indian Investors Turn Cautious On Compliance Concerns

A rising number of enforcement actions by major drug regulators like the U.S. FDA is slowly making investors cautious about the longer term repercussions on earnings of Indian drug makers.

Topics

UsernamePublicRestriction

Register

LL1133833

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel